Abstract: Implementations of the present disclosure relate to radio frequency (RF) connection. In the implementations, an access point (AP) comprises an antenna module, a separation plate, a main board, and a connector. The antenna module is fixed on the first surface of the separation plate. The connector comprises an inner conductor and an outer conductor passing through a hole in the separation plate and connects the trace of the antenna module with the electronic components in the main board. The inner conductor and the outer conductor are retractable along a direction perpendicular to the main board. In this way, by directly connecting the antenna with the main board by a retractable connector, additional cables can be spared without sacrificing the mechanical performance of the connection structure.

Abstract: AB/or mounting an electronic device to a ceiling suspension system is disclosed. The adjustable mounting bracket assembly includes clips, a device holder, and a base component having a plurality of first apertures. The clips are disposed spaced apart from each other and configured to engage with opposite edges of a beam of the ceiling suspension system. Each clip includes locking knobs, where each of the locking knobs is configured to be received within one of the plurality of first apertures to attach the clips to the base component, and the plurality of first apertures are arranged to allow the clips to be attached to the base component in a plurality of configurations including different separation distances between the clips. The device holder is coupled to the base component, where the device holder is configured to mount the electronic device to the adjustable mounting bracket assembly.

Abstract: A ceiling mount comprises a mounting plate to be coupled to an electronic device and two clips to be mounted to a ceiling rail. The clips comprise engagement members to engage with opposite sides of the ceiling rail, respectively, and support arms movably coupling the engagement members to the mounting plate. One of the support arms of each clip comprises linear gear teeth. The ceiling mount also comprises a circular gear coupled to the mounting plate and engaged with the respective linear gear teeth of the clips, and a pawl engaged with the circular gear and movable between a first state and a second state. In the first state of the pawl, the engagement members can be moved toward one another and are prevented from being moved away from one another, and in the second state of the pawl, the engagement members can be moved away from one another.

Abstract: The present disclosure provides a thermal insulation apparatus and a crucible production device. The thermal insulation apparatus is configured for supporting a mold, and includes: a housing, a first flange, a second flange and a plurality of reinforcing members, and the housing, the first flange and the second flange are coaxially arranged. An inner wall of the housing is enclosed to form an accommodating cavity, and the accommodating cavity is configured for accommodating the mold; a water-cooling cavity is enclosed between the inner wall and an outer wall of the housing; the first flange is connected to a top portion of the housing, so as to fix an upper edge of the mold to the top portion of the housing; the second flange is connected to a bottom portion of the housing; and the plurality of reinforcing members are arranged between the bottom portion of housing and second flange.

Abstract: A needling device includes: a needling assembly, a support, a base and a bearing frame. The base is provided inside the bearing frame, and the base is for bearing the preform body. The support is provided with a guide rail. The needling assembly is slidably connected to the support, and may slide along the guide rail, to needle the preform body. The needling assembly may perform an all-around needling operation to the circular-arc surface of the preform body, and depth and density of the needling by the needling assembly to the circular-arc surface of the preform body are even, which may prevent deformation and layering of the preform body during the deposition, to improve the processing quality of the preform body.

Abstract: Provided are a vapor injection device and a compressor. The vapor injection device includes an injector valve plate, an injector plate, and an injector reed valve. One side of the injector plate facing toward the injector valve plate is provided with an avoidance groove. A guide post is disposed protruding from one side of the injector plate facing away from the injector valve plate. The guide post is inserted into a fixed scroll of the compressor and provided with an injection channel. A vapor injection inlet cavity is formed between the rear housing, the injector valve plate, and the fixed scroll. The injector reed valve is disposed between the injector valve plate and the injector plate and attaches to the injector valve plate, the injector reed valve is provided with a movable sheet, and the movable sheet, the injector valve plate and the avoidance groove form a one-way valve structure.

Abstract: The present invention relates to compounds of the formula and the pharmaceutically acceptable salts and esters thereof, a process for their manufacture, medicaments containing them as well as the use of these compounds as pharmaceutically active agents. The compounds show antiproliferative activity and may be especially useful for the treatment of cancer.

Abstract: The present invention provides compounds according to formula I having the designations provided herein, and pharmaceutically acceptable salts and esters thereof. These compounds inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity.

Abstract: The present invention provides compounds according to formula I and pharmaceutically acceptable salts and esters thereof, having the designations provided herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity

Abstract: Disclosed are novel pyrimido compounds that are selective inhibitors of both KDR an FGFR kinases and are selective against LCK. These compounds and their pharmaceutically acceptable salts are anti-proliferative agents useful in the treatment or control of solid tumors, in particular breast, colon, lung and prostate tumors. Also disclosed are pharmaceutical compositions containing these compounds and methods of treating cancer.

Abstract: The present invention provides compounds having formula (II): wherein X, n, R1–R12 are defined herein, or a pharmaceutically acceptable salt thereof. The invention also provides a pharmaceutical composition comprising a therapeutically effective amount of a compound represented by formula (II) and a pharmaceutically acceptable carrier or excipient. The invention further provides a method for treating cancer comprising administering to a patient in need of such treatment a therapeutically effective amount of a compound represented by formula (II).

Abstract: The present invention provides compounds having formula (I): and formula (II): wherein X, n, and R1-R12 are defined herein, or a pharmaceutically acceptable salt thereof. The invention also provides a pharmaceutical composition comprising a therapeutically effective amount of a compound represented by formula (I) or (II) and a pharmaceutically acceptable carrier or excipient. The invention further provides a method for treating cancer comprising administering to a patient in need of such treatment a therapeutically effective amount of a compound represented by formula (I) or (II).

Abstract: The present invention provides compounds according to formula I 1

Abstract: The present invention provides compounds according to formula I and pharmaceutically acceptable salts and esters thereof, having the designations provided herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity.

Abstract: The present invention provides compounds according to formula I and formula II and pharmaceutically acceptable salts and esters thereof, having the designations provided herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity.

Abstract: The present invention provides compounds having formula (I): 1

Abstract: The present invention provides compounds according to formula I and formula II and pharmaceutically acceptable salts and esters thereof, having the designations provided herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity.

Abstract: Disclosed are novel pyrimido compounds that are selective inhibitors of both KDR an FGFR kinases and are selective against LCK. These compounds and their pharmaceutically acceptable salts are anti-proliferative agents useful in the treatment or control of solid tumors, in particular breast, colon, lung and prostate tumors. Also disclosed are pharmaceutical compositions containing these compounds and methods of treating cancer.

Abstract: The present invention provides compounds according to formula I and formula II and pharmaceutically acceptable salts and esters thereof, having the designations provided herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity

Abstract: The present invention provides compounds according to formula I and formula II and pharmaceutically acceptable salts and esters thereof, having the designations provided herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity.